Nested Therapeutics Funding: $125M Raised, Series A (2022)
Nested Therapeutics is based in Cambridge, Massachusetts. It has raised $125M in total funding. Latest round: Series A.
Nested Therapeutics funding overview
Nested Therapeutics is based in Cambridge, Massachusetts. Nested Therapeutics has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2022. The round record for Nested Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Goldman Sachs Asset Management, Versant Ventures, Foresite Capital, Avidity Partners, Cowen Healthcare Investments, Section 32. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Nested Therapeutics funding
How much has Nested Therapeutics raised?
Nested Therapeutics has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Nested Therapeutics?
Goldman Sachs Asset Management, Versant Ventures, Foresite Capital, Avidity Partners, Cowen Healthcare Investments, Section 32 are named among the investors backing Nested Therapeutics.
What was the latest Nested Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2022.
Where is Nested Therapeutics based?
Nested Therapeutics is based in Cambridge, Massachusetts.
When did Nested Therapeutics last raise?
The last disclosed Nested Therapeutics round closed in October 2022 at Series A.
Totals shown for Nested Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
